Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy.
Zhou J, Feng J, Wu Y, Dai HQ, Zhu GZ, Chen PH, Wang LM, Lu G, Liao XW, Lu PZ, Su WJ, Hooi SC, Ye XP, Shen HM, Peng T, Lu GD.
Zhou J, et al. Among authors: lu g, lu gd, lu pz.
Exp Mol Med. 2022 Nov;54(11):2007-2021. doi: 10.1038/s12276-022-00878-x. Epub 2022 Nov 16.
Exp Mol Med. 2022.
PMID: 36385558
Free PMC article.